
Prof.
Jerry Eichler: Research Interests
|
RESEARCH PROJECTS
POST-TRANSLATIONAL
MODIFICATION IN ARCHAEA
One
of the first hurdles to be negotiated in the post-genomic era involves the
description of the entire protein content of the cell, the proteome. Such
efforts are presently complicated by the various post-translational
modifications proteins can experience, including glycosylation, lipid
attachment, phosphorylation, methylation, disulfide bond formation and
proteolytic cleavage. Whereas these and other post-translational protein
modifications have been well-characterized in Eukarya and Bacteria,
post-translational modification in Archaea has received far less attention.
Although archaeal proteins can undergo post-translational modifications
reminiscent of what their eukaryal and/or bacterial counterparts experience,
examination of archaeal post-translational modification often reveals aspects
of post-translational modification not previously observed in the other two
domains of life. In some cases, post-translational modification allows a
protein to survive the extremophilic conditions often encountered by Archaea.
Various post-translational modifications experienced by archaeal proteins, the
molecular steps leading to these modifications as well as the role played by
post-translational modification in Archaea are currently being investigated.
Signal
peptide cleavage
Across evolution, type I signal peptidases are responsible for the
cleavage of secretory signal peptides from proteins following their
translocation across membranes. In Archaea, type I signal peptidases combine
domain-specific features alongside traits found in either their eukaryal or
bacterial counterparts. Eukaryal and bacterial type I signal peptidases differ
in terms of catalytic mechanism, pharmacological profile and oligomeric
status. We have recently described genes encoding Sec11a and Sec11b, two type
I signal peptidases of the halophilic archaeon Haloferax
volcanii (Fine et al., 2006). Although both genes are
expressed in cells grown in rich medium, gene deletion approaches suggest that
Sec11b, but not Sec11a, is essential. For purification purposes, tagged
versions of the protein products of both genes were expressed in transformed Haloferax
volcanii, with Sec11a and Sec11b being fused to a cellulose-binding domain
capable of interaction with cellulose in hypersaline surroundings. Employing
an in vitro signal peptidase assay designed for use with high salt
concentrations such as those encountered by halophilic archaea like Haloferax
volcanii, the signal peptide-cleaving activity of both isolated membranes
and purified Sec11a and Sec11b was addressed. The results show that the two
enzymes differentially cleave the assay substrate, raising the possibility
that the Sec11a and Sec11b serve distinct physiological functions.
While tending to share little overall resemblance,
SPases in Eukarya and Bacteria include five regions of significant sequence
homology, termed boxes A-E, with boxes B-E participating in the catalytic
cycle of the enzyme. Nonetheless, bacterial and eukaryal SPases differ
enzymatically and structurally. In the bacterial enzyme, the box B region
contains the conserved nucleophilic Ser-90 (Escherichia
coli numbering) residue, while the proposed general base Lys-145 is found
in box D. Ser-90 and Lys-145 are believed to form the catalytic dyad
responsible for the proteolytic action of the enzyme. By contrast, eukaryal
type I SPases have replaced the essential lysine of the bacterial catalytic
dyad with a histidine residue. Thus, while their catalytic mechanism remains
to be elucidated, eukaryal SPases may rely on either a Ser-His dyad or a
Ser-His-Asp triad for catalytic activity rather than the Ser-Lys dyad employed
by the bacterial enzyme. The bacterial and eukaryal enzymes also differ in
terms of their oligomeric status. Unlike the bacterial enzyme, which functions
independently, i.e. as a single encoded polypeptide, eukaryal SPases function
as part of a multisubunit SPase complex (SPC).
|
|
Whereas type I SPases
are relatively well-described in Bacteria and Eukarya, little is known of
signal peptide cleavage in Archaea. While containing the
evolutionarily-conserved regions of sequence homology, archaeal SPases lack
the conserved lysine of the bacterial Ser-Lys catalytic dyad, and, like
Eukarya, contain a histidine residue at this position. Thus, archaeal SPases
may rely on a catalytic mechanism similar to that used by the eukaryal enzyme.
The inability of genomic searches to thus far detect Eukarya-like SPase
complex subunits in Archaea suggests that the archaeal enzyme operates
independently, as in Bacteria. Furthermore, like bacterial SPases, certain
archaeal enzymes include a stretch of residues not found in eukaryal SPases
that comprises domain II, a structural motif of unknown function. Thus,
current understanding suggests that archaeal SPase may represent an
evolutionary intermediate between present-day eukaryal and bacterial enzymes.
|
|
Both Sec11a and Sec11b are expressed in
H. volcanii but only Sec11b is
essential. A.
RNA was extracted from H. volcanii
and used to direct the synthesis of cDNA. PCR was then performed in the
absence of nucleic acids (- ; lane 1), or in the presence of genomic DNA
(+DNA; lane 2), total RNA (+RNA; lane 3) or cDNA (+cDNA; lane 4) using primers
against either sec11a (left panel)
or sec11b (right panel). B. PCR amplification of H.
volcanii cells transformed with plasmids pIDT-Sec11a or pIDT-Sec11b,
designed to delete either sec11a or
sec11b, respectively. The arrows show the positions of the PCR
amplification product encoding the Sec11a or Sec11b flanking regions separated
by the H. volcanii trpA gene,
presented in the last lane of each panel. Also shown in each panel are PCR
products using genomic DNA (lane 1), genomic DNA including the integrated
pIDT-Sec11a or pIDT-Sec11b plasmids (lane 2), and the same DNA taken from
cells grown in tryptophan-free, 5-FOA- and uracil-containing medium, i.e.
following expulsion of the plasmid and native sec11a- or
sec11b-encoding gene (lane 3), as template. In the right panel, lane 4
shows the PCR product of the cells considered in lane 3 but returned to
tryptophan-containing medium such that DNA encoding the sec11a
or sec11b flanking regions
separated by the H. volcanii trpA
gene is expelled from the genome with the plasmid. C. RNA was extracted from H.
volcanii cells from which the Sec11a-encoding gene had been deleted and
used to direct the synthesis of cDNA. PCR was then performed in the absence of
nucleic acids (- ; lane 1), or in the presence of genomic DNA taken from
untreated cells (+DNA; lane 2), or total RNA (+RNA; lane 3) or cDNA (+cDNA;
lane 4) from the deletion strain, using primers against either sec11a
(left panel) or sec11b (right panel).
|
|
Purified CBD-Sec11a and
CBD-Sec11b are active. A.
CBD-Sec11a and B. CBD-Sec11b were purified and tested for their abilities to
release the signal peptide (SP) domain from the reporter substrate SP-CBD.
Incubations were conducted in the presence of purified enzyme and substrate,
enzyme alone or substrate alone, from 0 to 60 minutes.
|
|
N-glycosylation
in Archaea
|
|
A
major project in the lab addresses characterization of the N-glycosylation
process in Haloferax volcanii.
Initially (Abu Qarn and Eichler, 2006), putative H.
volcanii homologues of genes involved in eukaryal or bacterial
N-glycosylation were identified by bioinformatics. RT-PCR confirmed that the
proposed N-glycosylation genes are transcribed, indicative of true proteins
being encoded. Where families of related gene sequences were detected,
differential transcription of family members under a variety of physiological
and environmental conditions was shown. Gene deletions point to certain genes
as being essential yet revealed that others are not. Thus, with genes
putatively involved in H. volcanii
protein glycosylation identified and the ability to address the roles played
by the encoded polypeptides in modifying a reporter glycoprotein, the steps of
the archaeal N-glycosylation pathway can be defined.
Gene deletion shows that alg5-A is essential for H.
volcanii survival.
(A) PCR was performed using primers against flanking regions of alg5-A
and as template, DNA isolated from background strain cells (lane 1), from
plasmid-incorporating cells (lane 2), or from cells in which the plasmid and
native alg5-A had been expelled
(lane 3). (B) RT-PCR was performed using primers against alg5-A (upper panel) or alg5-B
(lower panel). As template, DNA (lane 2), RNA (lane 3) or cDNA (lane 4) from
cells lacking alg5-A was used. DNA
from background cells served as template in control reactions (lane 1).
|
Deletion
of alg5-A affect S-layer
glycoprotein glycosylation.
Equivalent aliquots of H. volcanii
background strain cells and cells lacking alg5-A
were either Coomassie blue-stained (CBB; upper panel) or glycan-stained with
periodic acid-Schiff reagent (PAS; middle panel) or a DIG-based reagent (DIG;
lower panel).
|
|
Lipid
modification in Archaea
|
|
H.
volcanii cells are
surrounded by a protein shell solely comprised of the S-layer glycoprotein.
Using pulse chase radiolabelling and cell fractionation studies, we have
revealed that newly-synthesized S-layer glycoprotein undergoes a maturation
step following translocation of the protein across the plasma membrane.
(Eichler, 2001; Konrad and Eichler, 2001). The processing step is due to a
mevalonic acid-based lipid modification of the protein. Studies aimed at
describing the mechanism of this post-translational modification are
on-going.
 Maturation of
the H. volcanii S-layer
glycoprotein. Cells
were [35S]-metabolically radiolabeled and then chased with an
excess of unlabeled methionine. Aliquots were removed immediately prior to and
then at intervals following onset of the unlabeled methionine chase. The
samples were then examined by 7.5% SDS-PAGE and fluorography.
2D
gel electrophoresis reveals differences in the hydrophobicity of the mature
and immature versions of the S-layer glycoprotein. An aliquot of cells subjected to pulse chase
radiolabelling was removed 4 min after the onset of chase and examined by
non-denaturing gel electrophoresis in the presence of 0.5% Triton X-100. The
gel lane was cut and applied horizontally to the top of the 3% stacking gel of
a 7.5% separating SDS-PAGE gel and electrophoresis was performed as usual. The
gel was then dried and examined by fluorography. The directions of
electrophoresis under non-denaturing and denaturing (i.e., SDS-PAGE) are shown
at the top and to the left of the gel, respectively. Arrows depict the
positions of the mature and immature S-layer glycoprotein.
The H.
volcanii S-layer glycoprotein can be labeled by [3H] mevalonic
acid.
H. volcanii cells were grown in the
presence of [3H] mevalonic acid. Aliquots were then removed and
processed for SDS-PAGE and examined by fluorography (lane 1), immunoblotting
with anti-S-layer glycoprotein antibodies (lane 2) or PAS staining (lane 3).
The arrow on the left depicts the position of the S-layer glycoprotein, while
the position of molecular weight markers are shown on the right.
|
|
PROTEIN TRANSLOCATION IN ARCHAEA
|
|
In Archaea, a
variety of extracytoplasmic proteins must be translocated into and across the
plasma membrane. These include membrane proteins, secreted enzymes and the
components of the protein based surface layer found in numerous archaeal
species. However, in contrast to the well-studied phenomena of protein
translocation across the bacterial plasma membrane or across the eukaryotic ER
membrane (the topological homologue of the prokaryotic plasma membrane), very
little is understood of how proteins cross the plasma membrane of Archaea. Our
research is aimed at elucidating the various processes, components and
mechanisms involved in protein translocation across the archaeal plasma
membrane.
|
Dissection
of the archaeal SRP pathway
The challenge of transfering proteins across
phospholipid-based membranes begins with correct targetting to proteinaceous
translocation complexes embedded in the membrane. Eukarya, Bacteria and
Archaea all contain components of the signal recognition particle (SRP), a
ribonucleoprotein complex involved in the delivery of nascent proteins to
translocation sites. In Eukarya, the SRP pathway is relatively
well-characterized, while significant strides in elucidating the role of
bacterial SRP have been realized in recent years. In contrast, little is known
about the SRP pathway in Archaea (Zwieb and Eichler, 2002). Accordingly, our
group is looking at various aspects of archaeal SRP composition, assembly and
function (Tozik et al., 2002).
Co-translational membrane protein in insertion in Archaea
In H. volcanii,
ribosomes are found in the cytoplasm and membrane-bound at similar levels.
Transformation of H. volcanii to
express chimeras of the translocon components SecY and SecE fused to a
cellulose-binding domain substantially decreased ribosomal membrane-binding,
relative to non-transformed cells, likely due to steric hinderance by the
cellulose-binding domain. Decreased ribosomal binding selectively affected
membrane protein levels, suggesting that membrane insertion occurs
co-translationally in Archaea (Ring and Eichler, 2004).
Nascent membrane protein biogenesis is reduced in CBD-SecE- and
CBD-SecY-expressing H. volcanii
cells. A.
The radioactivity associated with the soluble and membrane protein fractions
of metabolically [35S]cysteine/methionine radiolabelled background
(WT), CBD-SecE- and CBD-SecY-expressing H.
volcanii cells, grown to identical densities, was assessed by ß-scintillation
counting (A) or SDS-PAGE and fluorography (B). A. The radioactivity present in
5 µl samples was measured.
|
|
|

|